Phase 2, randomised placebo-controlled trial to evaluate the efficacy and safety of an anti-GM-CSF antibody (KB003) in patients with inadequately controlled asthma

por Molfino, Nestor A, Kuna, Piotr, Leff, Jonathan A, Oh, Chad K, Singh, Dave, Chernow, Marlene, Sutton, Brian, Yarranton, Geoffrey
Publicado 2016

Antibody-mediated depletion of CCR10(+)EphA3(+) cells ameliorates fibrosis in IPF

por Hohmann, Miriam S., Habiel, David M., Espindola, Milena S., Huang, Guanling, Jones, Isabelle, Narayanan, Rohan, Coelho, Ana Lucia, Oldham, Justin M., Noth, Imre, Ma, Shwu-Fan, Kurkciyan, Adrianne, McQualter, Jonathan L., Carraro, Gianni, Stripp, Barry, Chen, Peter, Jiang, Dianhua, Noble, Paul W., Parks, William, Woronicz, John, Yarranton, Geoffrey, Murray, Lynne A., Hogaboam, Cory M.
Publicado 2021